Rajasekar Sunil
EVP Chief Prod & Strat Officer
Rajasekar Sunil has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Oct 19, 2026.
On the most recent filing, Rajasekar Sunil is listed as EVP Chief Prod & Strat Officer at HEALTHEQUITY, INC. Inside the rolling window, Rajasekar Sunil reported 2 open-market purchases totaling $12K in HQY and 2 open-market sales totaling $13K in HQY. The largest disclosed transaction in the window is a sale of 108 HQY shares on Aug 24, 2026, worth $11K.
Companies traded
Other insiders at HQY
Insider Buying
$12K
reported purchases (SEC code P)
Insider Selling
$13K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rajasekar Sunil made?
Rajasekar Sunil has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.
Which companies does Rajasekar Sunil trade?
Rajasekar Sunil has filed SEC Form 4 disclosures for 1 company, including HQY.
When was Rajasekar Sunil's most recent SEC Form 4 filing?
Rajasekar Sunil's most recent SEC Form 4 filing on Tracefour is dated Oct 19, 2026.
What is Rajasekar Sunil's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rajasekar Sunil is listed as EVP Chief Prod & Strat Officer.
What is Rajasekar Sunil's total buy and sell value in the current window?
Inside the rolling retention window, Rajasekar Sunil bought $12K and sold $13K based on SEC Form 4 filings.
What was Rajasekar Sunil's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 108 HQY shares on 2026-08-24, worth $11K, per SEC Form 4 filings.